These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11845922)

  • 1. Life-cycle preferences over consumption and health: a comment on Bleichrodt and Quiggin.
    Klose T
    J Health Econ; 2002 Jan; 21(1):161-6; discussion 167-8. PubMed ID: 11845922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The additive utility assumption of the QALY model revisited.
    Gandjour A; Gafni A
    J Health Econ; 2010 Mar; 29(2):325-8; author reply 329-31. PubMed ID: 20004033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis?
    Bleichrodt H; Quiggin J
    J Health Econ; 1999 Dec; 18(6):681-708. PubMed ID: 10847930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring the social importance of concentration or dispersion of individual health benefits.
    Rodríguez-Míguez E; Pinto-Prades JL
    Health Econ; 2002 Jan; 11(1):43-53. PubMed ID: 11788981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double discounting of QALYs.
    MacKeigan LD; Gafni A; O'Brien BJ
    Health Econ; 2003 Feb; 12(2):165-9. PubMed ID: 12563665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QALYs, standard gambles, and the expected budget constraint.
    Blomqvist A
    J Health Econ; 2002 Mar; 21(2):181-95. PubMed ID: 11939237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes.
    Donaldson C; Birch S; Gafni A
    Health Econ; 2002 Jan; 11(1):55-70. PubMed ID: 11788982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A utility-theoretic model for QALYs and willingness to pay.
    Klose T
    Health Econ; 2003 Jan; 12(1):17-31. PubMed ID: 12483758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New tests of QALYs when health varies over time.
    Bleichrodt H; Filko M
    J Health Econ; 2008 Sep; 27(5):1237-49. PubMed ID: 18644640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditions for the near equivalence of cost-effectiveness and cost-benefit analyses.
    Bala MV; Zarkin GA; Mauskopf JA
    Value Health; 2002; 5(4):338-46. PubMed ID: 12102696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QALY maximisation and people's preferences: a methodological review of the literature.
    Dolan P; Shaw R; Tsuchiya A; Williams A
    Health Econ; 2005 Feb; 14(2):197-208. PubMed ID: 15386656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QALYs (quality-adjusted life-years) versus HYEs (healthy years equivalents).
    Culyer AJ; Wagstaff A
    J Health Econ; 1993 Oct; 12(3):311-23. PubMed ID: 10129839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-social welfare functions: a reply to Hansen et al.
    Edlin R
    J Health Econ; 2004 Sep; 23(5):899-905. PubMed ID: 15353185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economics, health and health economics: HYEs (healthy-years equivalent) versus QALYs (quality-adjusted live-year).
    Gafni A; Birch S; Mehrez A
    J Health Econ; 1993 Oct; 12(3):325-39. PubMed ID: 10129840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Willingness to pay methods in health care: a sceptical view.
    Cookson R
    Health Econ; 2003 Nov; 12(11):891-4. PubMed ID: 14601152
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality-adjusted life-years. Ethical implications for physicians and policymakers.
    La Puma J; Lawlor EF
    JAMA; 1990 Jun; 263(21):2917-21. PubMed ID: 2110986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making.
    Shiroiwa T; Saito S; Shimozuma K; Kodama S; Noto S; Fukuda T
    Appl Health Econ Health Policy; 2016 Jun; 14(3):375-85. PubMed ID: 26940671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a kink in consumers' threshold value for cost-effectiveness in health care?
    O'Brien BJ; Gertsen K; Willan AR; Faulkner LA
    Health Econ; 2002 Mar; 11(2):175-80. PubMed ID: 11921315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longevity bias in cost-effectiveness analysis.
    Liu L; Rettenmaier AJ; Saving TR
    Health Econ; 2008 Apr; 17(4):523-34. PubMed ID: 17990284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.